approval
saveAMBRISENTAN — FDA approval
community read0 votes
Sponsor: APOTEX. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalAMBRISENTAN — FDA approvalFeb 17, 2026 · 230d ago
- approvalAMBRISENTAN — FDA approvalFeb 17, 2026 · 230d ago
- approvalAMBRISENTAN — FDA approvalApr 4, 2025 · 549d ago
- approvalAMBRISENTAN — FDA approvalApr 4, 2025 · 549d ago
- approvalAMBRISENTAN — FDA approvalApr 4, 2025 · 549d ago
- approvalAMBRISENTAN — FDA approvalAug 19, 2024 · 777d ago
- approvalAMBRISENTAN — FDA approvalAug 19, 2024 · 777d ago
- approvalAMBRISENTAN — FDA approvalAug 19, 2024 · 777d ago
same company · ±60 days · 6
- approvalBUPROPION HYDROCHLORIDE: BUPROPION HYDROCHLORIDE — FDA approvalOct 6, 2025
- recallApotex Corp. recall (Cls II)Oct 8, 2025
- recallApotex Corp. recall (Cls II)Oct 8, 2025
- approvalTICAGRELOR: TICAGRELOR — FDA approvalOct 28, 2025
- approvalaxitinib SR: AXITINIB — FDA approvalOct 30, 2025
- approvalBUPROPION HYDROCHLORIDE: BUPROPION HYDROCHLORIDE — FDA approvalNov 5, 2025
comments(0)
5-min edit window · permanent after that